Showing results (81-90 of 190) with videos related to
Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|August 6, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.Journal for Immunotherapy of Cancer|March 22, 2025
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapyThomas U Marron, Jason J Luke, Brianna Hoffner, et al.Critical Reviews in Oncology/Hematology|February 10, 2024
US physician perspective on the use of biomarker and ctDNA testing in patients with melanomaRachel A Fischer, Isabel Ryan, Kristine De La Torre, et al.Journal for Immunotherapy of Cancer|August 18, 2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Patrick A Ott, F Stephen Hodi, et al.European Journal of Cancer (Oxford, England : 1990)|September 25, 2021
Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibitionJianda Yuan, Anuradha Khilnani, Joshua Brody, et al.Frontiers in Oncology|December 13, 2021
Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World AnalysisMelissa L Bastacky, Hong Wang, Dylan Fortman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trialJason J Luke, David R D'Adamo, Mark A Dickson, et al.Cancer|March 23, 2022
Poorer survival outcomes in patients with multiple versus single primary melanomaLilit Karapetyan, Xi Yang, Andrew D Knight, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNAGeoffrey R Oxnard, Cloud P Paweletz, Yanan Kuang, et al.Science Immunology|February 23, 2020
Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomesTianshi Lu, Shidan Wang, Lin Xu, et al.Pageof 19